Patents by Inventor William F. Hoffman
William F. Hoffman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8264777Abstract: A portable electronic device (510) having a self illuminating display (200, 202, 204, 206, 300, 512) that reduces both the thickness of known displays and processing steps in the fabrication thereof is provided. The portable electronic device (510) includes an electrowetting display (200, 202, 204, 206, 300, 512) having a plurality of transparent layers defining a cavity (219). A combination of a first fluid (218, 236) and a second fluid (210, 234, 244, 254) are positioned in the cavity. First circuitry (224) is configured to be coupled to a first voltage source (222) for selectively repositioning the second fluid (210, 234, 244, 254) in relation to the first fluid (218, 236). A plurality of quantum dots (208, 360) is positioned within the second fluid (210, 234, 244, 254), and a light source (209, 309) is disposed contiguous to the plurality of layers.Type: GrantFiled: June 26, 2007Date of Patent: September 11, 2012Assignee: QD Vision, Inc.Inventors: Andrew F. Skipor, Marc K. Chason, William F. Hoffman, Krishna Kalyanasundaram, George T. Valliath
-
Patent number: 8184359Abstract: A laser projector display module for a handheld device may include an electronics module, a miniaturized light source module electrically connected with the electronics module, a scanner module electrically connected with the electronics module, and an optical assembly configured to direct light from the light source onto the scanner module. The scanner module and the light source module may abut the electronics module.Type: GrantFiled: December 27, 2006Date of Patent: May 22, 2012Assignee: Motorola Mobility, Inc.Inventors: William F. Hoffman, Tomasz L. Klosowiak, Lawrence E. Lach, Junhua Liu, Ion V. Nicolaescu, Min-Xian M. Zhang
-
Publication number: 20090002806Abstract: A portable electronic device (510) having a self illuminating display (200, 202, 204, 206, 300, 512) that reduces both the thickness of known displays and processing steps in the fabrication thereof is provided. The portable electronic device (510) includes an electrowetting display (200, 202, 204, 206, 300, 512) having a plurality of transparent layers defining a cavity (219). A combination of a first fluid (218, 236) and a second fluid (210, 234, 244, 254) are positioned in the cavity. First circuitry (224) is configured to be coupled to a first voltage source (222) for selectively repositioning the second fluid (210, 234, 244, 254) in relation to the first fluid (218, 236). A plurality of quantum dots (208, 360) is positioned within the second fluid (210, 234, 244, 254), and a light source (209, 309) is disposed contiguous to the plurality of layers.Type: ApplicationFiled: June 26, 2007Publication date: January 1, 2009Applicant: MOTOROLA, INC.Inventors: Andrew F. Skipor, Marc K. Chason, William F. Hoffman, Krishna Kalyanasundaram, George T. Valliath
-
Publication number: 20080274107Abstract: The present invention relates to compounds which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions, such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.Type: ApplicationFiled: April 21, 2008Publication date: November 6, 2008Inventors: Mark E. Fraley, Kenneth L. Arrington, Mark T. Bilodeau, George D. Hartman, William F. Hoffman, Yuntae Kim, Randall W. Hungate
-
Publication number: 20080210929Abstract: An organic thin film transistor is formed using an organic semiconducting polymer that contains electrically conductive micro scale or nanoscale metallic plates, particulates, or rods dispersed in the polymer at a concentration less than the percolation threshold to form a semiconducting matrix. The electrically conductive particulates are dispersed to provide a multidimensional micro scale network so that the materials do not provide electrical conductivity between themselves but only between an individual particulate and the organic semiconductor. The transconductance value of the semiconducting matrix is at least one order of magnitude greater than the transconductance value of the neat organic semiconductor, providing a switching speed from an ‘off’ state to an ‘on’ state at least one order of magnitude greater than a switching speed of the neat organic semiconductor.Type: ApplicationFiled: March 1, 2007Publication date: September 4, 2008Applicant: Motorola, Inc.Inventors: William F. Hoffman, Andrew F. Skipor
-
Publication number: 20080172197Abstract: A display (1100) comprises a passive screen (106, 502, 700, 1114) printed with a pattern (404) of different color quantum dots (602, 604, 606) that is excited by scanning a laser (130, 1108) over the screen (106, 502, 700, 1114). The display (1100) can be incorporated into a handheld device (100, 1200) to improve the use-ability of the device (100, 1200).Type: ApplicationFiled: January 11, 2007Publication date: July 17, 2008Applicant: MOTOROLA, INC.Inventors: Andrew F. Skipor, Marc K. Chason, William F. Hoffman, Krishna D. Jonnalagadda, Mark A. Tarlton, George T. Valliath, Jerzy Wielgus
-
Publication number: 20080158653Abstract: A laser projector display module for a handheld device may include an electronics module, a miniaturized light source module electrically connected with the electronics module, a scanner module electrically connected with the electronics module, and an optical assembly configured to direct light from the light source onto the scanner module. The scanner module and the light source module may abut the electronics module.Type: ApplicationFiled: December 27, 2006Publication date: July 3, 2008Applicant: Motorola, Inc.Inventors: William F. Hoffman, Tomasz L. Klosowiak, Lawrence E. Lach, Junhua Liu, Ion V. Nicolaescu, Min-Xian M. Zhang
-
Patent number: 7378411Abstract: The present invention relates to thienopyrimidinone compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.Type: GrantFiled: December 2, 2002Date of Patent: May 27, 2008Assignee: Merck & Co., Inc.Inventors: Mark E. Fraley, George D. Hartman, William F. Hoffman
-
Patent number: 7348440Abstract: The present invention relates to dihydropyrrole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.Type: GrantFiled: June 12, 2003Date of Patent: March 25, 2008Assignee: Merck & Co., Inc.Inventors: Kenneth L. Arrington, Paul J. Coleman, Christopher D. Cox, Mark E. Fraley, Robert M. Garbaccio, George D. Hartman, William F. Hoffman, Edward S. Tasber
-
Patent number: 7329762Abstract: The present invention relates to phosphate ester prodrugs of dihydropyrrole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.Type: GrantFiled: June 8, 2004Date of Patent: February 12, 2008Assignee: Merck & Co., Inc.Inventors: Mark E. Fraley, Robert M. Garbaccio, George D. Hartman, William F. Hoffman
-
Patent number: 7262187Abstract: The present invention relates to azolopyrimidinone compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.Type: GrantFiled: December 2, 2002Date of Patent: August 28, 2007Assignee: Merck & Co., Inc.Inventors: Mark E. Fraley, George D. Hartman, William F. Hoffman
-
Patent number: 7262186Abstract: The present invention relates to azolopyriniidinone compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.Type: GrantFiled: December 2, 2002Date of Patent: August 28, 2007Assignee: Merck & Co., Inc.Inventors: Mark E. Fraley, George D. Hartman, William F. Hoffman
-
Patent number: 7251569Abstract: Methods, systems, and computer program products for analyzing a product are disclosed. The product includes parts supplied by suppliers. Each part includes materials, each material includes substances, and each substance has a respective substance amount. A database includes relationship information for the product, parts, materials, substances and substance amounts. The product is analyzed by, first, receiving instructions to select at least one of the product, the parts, or the materials for analysis. Next, responsive to the received instructions, relationship information is retrieved from the database for the selected product, parts, and materials. Finally, the retrieved relationship information is processed to determine at least one of (1) a materials breakdown or (2) a compliance status for the selected product, parts, or materials.Type: GrantFiled: January 26, 2005Date of Patent: July 31, 2007Assignee: Synapsis Enterprise LLCInventors: P. German Avila, William F. Hoffman, III, Kurk W. Kan, Andrew M. Wertkin
-
Patent number: 7186723Abstract: The present invention relates to compounds which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions, such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.Type: GrantFiled: August 26, 2002Date of Patent: March 6, 2007Assignee: Merck & Co., Inc.Inventors: Jennifer P. Peckham, William F. Hoffman, Kenneth L. Arrington, Mark E. Fraley, George D. Hartman, Yuntae Kim, Barbara Hanney, Keith L. Spencer
-
Patent number: 7109204Abstract: The present invention relates to compounds which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions, such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.Type: GrantFiled: July 26, 2002Date of Patent: September 19, 2006Assignee: Merck & Co., Inc.Inventors: Mark E. Fraley, Kenneth L. Arrington, William F. Hoffman, George D. Hartman, Jennifer P. Peckham
-
Patent number: 7060705Abstract: The present invention relates to quinazolinone compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.Type: GrantFiled: November 1, 2002Date of Patent: June 13, 2006Assignee: Merck & Co., Inc.Inventors: Mark E. Fraley, William F. Hoffman
-
Publication number: 20040249042Abstract: A coating for assisting in the removal of components from devices comprising a polymer and a microwave absorbing substance dispersed in the polymer, so that when the coating is applied on a surface of a device and overlaid with a component and exposed to microwaves, the microwave absorbing substance absorbs the microwaves and allows for the component to be separated from the device.Type: ApplicationFiled: June 9, 2003Publication date: December 9, 2004Applicant: MOTOROLA, INC.Inventors: Steven M. Scheifers, William F. Hoffman
-
Publication number: 20040235875Abstract: The present invention relates to compounds which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions, such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.Type: ApplicationFiled: January 29, 2004Publication date: November 25, 2004Inventors: Mark E. Fraley, Kenneth L Arrington, William F Hoffman, George D Hartman, Jennifer P Peckham
-
Publication number: 20040235826Abstract: The present invention relates to compounds which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions, such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.Type: ApplicationFiled: February 24, 2004Publication date: November 25, 2004Inventors: Jennifer P. Peckham, William F. Hoffman, Kenneth L. Arrington, Mark E. Fraley, George D. Hartman, Yuntae Kim, Barbara Hanney, Keith L. Spencer
-
Patent number: 6794393Abstract: The present invention relates to compounds which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions, such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.Type: GrantFiled: April 18, 2002Date of Patent: September 21, 2004Assignee: Merck & Co., Inc.Inventors: Mark E. Fraley, Kenneth L. Arrington, Mark T. Bilodeau, George D. Hartman, William F. Hoffman, Yuntae Kim, Randall W. Hungate